MARKETSGlenmark Pharma Gains 1.5% on US FDA Nod for OlopatadineDhruva KulkarniMarch 21, 2025March 21, 2025 by Dhruva KulkarniMarch 21, 2025March 21, 202511848 Shares of Glenmark Pharmaceuticals Ltd surged 1.5% to touch a day’s high of Rs 1,509 on 21st March after the firm announced that its subsidiary,...